| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/19/2006 | WO2005068632A8 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME |
| 10/19/2006 | WO2005016132A3 Diagnostics for sars virus |
| 10/19/2006 | WO2004084810A3 Novel imidazoline receptor homologs |
| 10/19/2006 | WO2004076638A3 Polynucleotides and polypeptides in plants |
| 10/19/2006 | WO2004074302A3 Autosomal recessive polycystic kidney disease nucleic acids and peptides |
| 10/19/2006 | WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 10/19/2006 | US20060236433 Nicotiana hybrids and plant varieties for use in production of pharmaceuticals |
| 10/19/2006 | US20060236423 Insecticidal plant cyclotide with activity against homopteran insects |
| 10/19/2006 | US20060236419 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 10/19/2006 | US20060236412 Porcine uroplakin ii promoter and the production method of useful proteins using said promoter |
| 10/19/2006 | US20060236411 Antagonists il-15 |
| 10/19/2006 | US20060236410 Protein specific for cardiac and skeletal muscle |
| 10/19/2006 | US20060235216 Sugar and lipid metabolism regulators in plants v |
| 10/19/2006 | US20060235215 Stress-related polypeptides and uses therefor |
| 10/19/2006 | US20060235205 Drying; preserving; noncrosslinking; no grinding; softening in peracetic acid, hydrochloric acid, oxalic acid, and/or acetic acid; peracetic acid, sodium perchlorate, periodic acid, hydriodic acid, trichloromelamine, difluoroacetic acid, chlorine dioxide, and/or hydrogen peroxide poring agent |
| 10/19/2006 | US20060235204 BMP-2 variants with improved properties |
| 10/19/2006 | US20060235203 MN gene and protein |
| 10/19/2006 | US20060235202 Neuronal polypeptide for use as antinociceptive, anesthetic and analgesic agents; receptor binding assay; vector; host cell |
| 10/19/2006 | US20060235201 Enduring T cell response |
| 10/19/2006 | US20060235200 Mutagenesis of aspergillus fungi and identification of genes essential for growth |
| 10/19/2006 | US20060235199 Reagent for amplifying amyloid fibrosis of amyloid ss-protein |
| 10/19/2006 | US20060234967 Human protooncogene and protein encoded therein |
| 10/19/2006 | US20060234965 Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 10/19/2006 | US20060234964 nucleatide sequences that code transforming growth factor beta (TGF- beta), for the treatment of autoimmune diseases such as inflammatory bowel disease |
| 10/19/2006 | US20060234945 Ophthalmic therapeutic composition |
| 10/19/2006 | US20060234938 Amino acid sequences which target pre-B-cell transformation related gene (PBX) expression for use in treatment of cell proliferative disorders; antiproliferative agents |
| 10/19/2006 | US20060234933 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
| 10/19/2006 | US20060234930 Use of dg008,dg065,dg210 or dg239 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 10/19/2006 | US20060234929 Rasgap derived peptide for selectively killing cancer cells |
| 10/19/2006 | US20060234928 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 10/19/2006 | US20060234927 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 10/19/2006 | US20060234926 Nucleic acid ligands and uses therefor |
| 10/19/2006 | US20060234925 Embryo implantation inhibitor |
| 10/19/2006 | US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis |
| 10/19/2006 | US20060234923 solid phase synthesis; solution phase synthesis; hairpin motifs; chemokine receptor 4 antagonists |
| 10/19/2006 | US20060234917 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 10/19/2006 | US20060234914 Fragments of proinsulin c-peptide |
| 10/19/2006 | US20060234912 Methods for modulating neuronal responses |
| 10/19/2006 | US20060234907 Albumin solution and process for the production thereof |
| 10/19/2006 | US20060234906 Structure of a complex of retinoblastoma protein bound to e2f, and uses thereof |
| 10/19/2006 | US20060234385 Polyglutamine repeat sequences |
| 10/19/2006 | US20060234368 Alga-origin promoter, intron and terminator |
| 10/19/2006 | US20060234367 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance |
| 10/19/2006 | US20060234357 Expression vector comprising nucleotide sequences associated with amino acid biosynthesis for transformation and propagation in cells; enhancing concentration of amino acids for use in medicines, animal feeds and cosmetics; bioreactors |
| 10/19/2006 | US20060234356 Novel polynucleotides encoding useful polypeptides in corynebacterium glutamicum ssp. lactofermentum |
| 10/19/2006 | US20060234352 Homogeneity and secretion of recombinant proteins in mammalian systems |
| 10/19/2006 | US20060234351 Yeast protein expression secretion system |
| 10/19/2006 | US20060234350 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 10/19/2006 | US20060234349 Fungal cell wall synthesis gene |
| 10/19/2006 | US20060234347 Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
| 10/19/2006 | US20060234346 Expression of mammalian proteins in Pseudomonas fluorescens |
| 10/19/2006 | US20060234343 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states |
| 10/19/2006 | US20060234339 Method of expressing protein having unnatural amino acid integrated thereinto |
| 10/19/2006 | US20060234337 Expression system for actinomycete-origin cytochrome p-450 in escherichia coli |
| 10/19/2006 | US20060234336 Methylotrophic bacterium for the production of recombinant proteins and other products |
| 10/19/2006 | US20060234318 agent for detecting a cancer, which comprises a monoclonal antibody that specifically binds to a Mina 53 peptide; produced by hybridoma FERM BP-10157 |
| 10/19/2006 | US20060234317 Method of screening |
| 10/19/2006 | US20060234314 Selective binding and analysis of macromolecules |
| 10/19/2006 | US20060234311 Isolating cells expressing secreted proteins |
| 10/19/2006 | US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2) |
| 10/19/2006 | US20060234305 Gene encoding G-protein coupled receptor and gene product thereof |
| 10/19/2006 | US20060234301 Detecting autoimmune and nervous system disfunction via ratio between glycans and immunoglobulin binding agent or antibodies; earlier stage dectection |
| 10/19/2006 | US20060234297 Screening method |
| 10/19/2006 | US20060234293 Polypeptide methods and means |
| 10/19/2006 | US20060234292 Methods of diagnosing and treating diabetes and insulin resistance |
| 10/19/2006 | US20060234291 Site selective acylation |
| 10/19/2006 | US20060234290 Novel genes and expression products therefrom |
| 10/19/2006 | US20060234289 Sp110, a polypeptide component of the nuclear body |
| 10/19/2006 | US20060234288 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 10/19/2006 | US20060234286 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
| 10/19/2006 | US20060234285 For treating or preventing inflammatory diseases, autoimmune diseases, graft versus host disease (GVHD), allergis, asthma, and/or hepatitis; drug screening |
| 10/19/2006 | US20060234284 Methods of using molecular constructs for detection of biochemical reactions |
| 10/19/2006 | US20060234283 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity |
| 10/19/2006 | US20060234282 Novel galanin receptor |
| 10/19/2006 | US20060234281 Novel galanin receptor |
| 10/19/2006 | US20060234271 Methods for the diagnosis and treatment of metastatic prostate tumors |
| 10/19/2006 | US20060234260 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 10/19/2006 | US20060234257 NOVX nucleic acids and their encoded polypeptides; diagnostic and therapeutic applications in the detection of a variety of diseases with differential expression in normal vs. diseased tissues, e.g., detection of a variety of cancers. |
| 10/19/2006 | US20060234255 Novel proteins and nucleic acids encoding same |
| 10/19/2006 | US20060234246 diagnosing cancer; drug screening; inhibiting growth of a tumor cell by modulating expression of a gene product |
| 10/19/2006 | US20060234233 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| 10/19/2006 | US20060234227 Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| 10/19/2006 | US20060234226 Non-affinity purification of proteins |
| 10/19/2006 | US20060234225 Height-related gene |
| 10/19/2006 | US20060234224 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 10/19/2006 | US20060234222 Soluble recombinant protein production |
| 10/19/2006 | US20060234214 Methods of detecting hepatitis C virus |
| 10/19/2006 | US20060234213 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses |
| 10/19/2006 | US20060234212 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 10/19/2006 | US20060234208 Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 10/19/2006 | US20060234206 environment-sensitive fluorophores which have spectroscopic behavior that is dependent on the physicochemical properties of the surrounding environment; 6-(Dimethylamino)-2,3-naphthalenedicarboylic anhydride |
| 10/19/2006 | US20060234205 In vitro test system for predicting patient tolerability of therapeutic agents |
| 10/19/2006 | US20060233855 Administering a synthetic polymer ( biodegradable, nonbiodegradable polymers e.g. polylactic acid, PTFE) attached to denatured, uncleaved fibrinogen being subject to proteolytic and hydrolytic degradation in a patient in need of bone tissue, thereby regenerating the bone or cartilage tissues |
| 10/19/2006 | US20060233854 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 10/19/2006 | US20060233839 Novel compounds |
| 10/19/2006 | US20060233836 Complex comprising peptide substrate such as synaptosomal associated protein, syntaxin, isoforms, vesicle-associated membrane protein, and motif of soluble NSF (N-ethylmaleimide-sensitive fusion protein) attachment protein receptor, reporter domain comprising red fluorescent protein |
| 10/19/2006 | US20060233835 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 10/19/2006 | US20060233832 Composition for the prophylaxis and treatment of HBV infections and HBV-mediated diseases |
| 10/19/2006 | US20060233827 85kDa neisserial antigen |
| 10/19/2006 | US20060233826 Nucleotide sequences coding chlamydial membrane protein for use in generating neutralizing antibody which prevents micoorganismal infection |